Longevity in the South Carolina Alzheimer's disease registry

被引:0
|
作者
Miller, Maggi C. [1 ]
Bawa, Eric Mishio [1 ]
Absher, John R. [2 ,3 ,4 ]
Bonilha, Leonard [5 ]
Ross, Lesley A. [4 ]
Chai, Hye Won [4 ]
Milano, Nicholas J. [6 ]
Adams, Robert J. [6 ]
机构
[1] Univ South Carolina, Dept Epidemiol & Biostat, Off Study Aging, Columbia, SC 29208 USA
[2] Univ South Carolina, Brain Hlth Network, Columbia, SC USA
[3] Univ South Carolina, Sch Med Greenville, Dept Med, Div Neurol, Greenville, SC USA
[4] Clemson Univ, Sch Hlth Res, Clemson, SC USA
[5] Univ South Carolina, Sch Med Columbia, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA
[6] Med Univ South Carolina, Dept Neurol, Charleston, SC USA
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; dementia; longevity; survival; registry; SURVIVAL-TIME; DEMENTIA; HEALTH; DIAGNOSIS; GENDER; MORTALITY; PEOPLE; DEATH; GAP; AGE;
D O I
10.3389/fneur.2024.1425495
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background South Carolina has arguably the most robust Alzheimer's Registry in the United States. For enhanced planning in both clinical practice and research and better utilization of the Registry data, it is important to understand survival after Registry entry. To this end, we conducted exploratory analyses to examine the patterns of longevity/survival in the South Carolina Alzheimer's Disease Registry.Methods The sample included 42,028 individuals in the South Carolina Alzheimer's Disease Registry (SCADR). Participants were grouped into four cohorts based on their year of diagnosis. Longevity in the Registry (LIR), or the length of survival in the registry, was calculated based on the years of reported diagnosis and death.Results The median LIR varied between 24 to 36 months depending on the cohort, with 75% of individuals in the three recent cohorts surviving for at least 12 months. Across all cohorts, 25% of the participants survived at least 60 months. The median LIR of females was longer than that of males. Individuals whose race was classified as Asian, American Indian, and other than listed had longer LIR compared to White, African American, and Hispanic individuals. Median LIR was shorter for Registry cases diagnosed at an earlier age (less than 65 years).Conclusion Our data indicate that significant longevity is to be expected in the SCADR but that there is interesting variability which needs to be explored in subsequent studies. The SCADR is a rich data source prime for use in research studies and analyses.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Neuroimaging findings in the Hong Kong Alzheimer's disease registry
    Abrigo, Jill
    Chan, Nga Yan
    Mok, Hazel
    Mok, Vincent
    Kwok, Timothy
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [22] Background and purpose of the consortium to establish a registry for Alzheimer's disease
    Buckholtz, N
    NEUROLOGY, 1997, 49 (03) : S1 - S1
  • [23] ANALYSIS OF INTERACTIONS BETWEEN ALZHEIMER'S DISEASE CANDIDATE GENES AND THEIR IMPACT ON LONGEVITY
    Zhbannikov, I.
    Ukraintseva, S.
    Arbeeva, L.
    Kovtun, M.
    Akushevich, I.
    Arbeev, K.
    Yashin, A. I.
    GERONTOLOGIST, 2016, 56 : 103 - 103
  • [24] The pitfalls of establishing a statewide vascular registry: The South Carolina experience
    Taylor, SM
    Robison, JG
    Langan, EM
    Crane, MM
    AMERICAN SURGEON, 1999, 65 (06) : 513 - 518
  • [25] Determination of population structure in the mayo Alzheimer's disease patient registry
    Melquist, S
    Crook, R
    Phillips, B
    Baker, M
    Adamson, J
    Mueller, R
    Petersen, RC
    Hutton, M
    NEUROBIOLOGY OF AGING, 2004, 25 : S502 - S502
  • [26] Vascular lesions and the consortium to establish a registry for Alzheimer's disease (CERAD).
    Mirra, S
    BRAIN PATHOLOGY, 2000, 10 (04) : 591 - 591
  • [27] The Italian version of Consortium to Establish a Registry of Alzheimer's Disease (CERAD)
    Lucca, Ugo
    Tettamanti, Mauro
    Quadri, Pierluigi
    ALZHEIMERS & DEMENTIA, 2008, 4 (04) : 310 - 310
  • [28] Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease
    O'Neill, Cora
    Kiely, Aoife P.
    Coakley, Meghan F.
    Manning, Sean
    Long-Smith, Caitriona M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 721 - 727
  • [29] Exceptional Parental Longevity Associated with Lower Risk of Alzheimer's Disease and Memory Decline
    Lipton, Richard B.
    Hirsch, Jamie
    Katz, Mindy J.
    Wang, Cuiling
    Sanders, Amy E.
    Verghese, Joe
    Barzilai, Nir
    Derby, Carol A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (06) : 1043 - 1049
  • [30] How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
    Richardson, Arlan
    Galvan, Veronica
    Lin, Ai-Ling
    Oddo, Salvatore
    EXPERIMENTAL GERONTOLOGY, 2015, 68 : 51 - 58